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Recently, much attention has been given to the problem of drug delivery through the cell-membrane in order to treat and manage
severaldiseases.Thediscoveryofcell penetratingpeptides(CPPs)representsamajorbreakthroughforthetransportoflarge-cargo
molecules that may be useful in clinical applications. CPPs are rich in basic amino acids such as arginine and lysine and are able to
translocate over membranes and gain access to the cell interior. They can deliver large-cargo molecules, such as oligonucleotides,
intocells.Endocytosisanddirectpenetrationhavebeensuggestedasthetwomajoruptakemechanisms,asubjectstillunderdebate.
Unresolved questions include the detailed molecular uptake mechanism(s), reasons for cell toxicity, and the delivery eﬃciency of
CPPs for diﬀerent cargoes. Here, we give a review focused on uptake mechanisms used by CPPs for membrane translocation and
certain experimental factors that aﬀect the mechanism(s).
1.Introduction
The cell membrane is the structure that protects living
cells from the surrounding environment, only allowing the
movement of compounds generally with small molecular
size across this barrier into the cell. Some drugs are large
hydrophilic molecules showing major limitations for their
penetration through the cell membrane. A group of short
peptides have been discovered that serve as delivery vectors
for large molecules. They may have been called by diﬀerent
names such as protein translocation domain, membrane
translocating sequence, Trojan peptide, or most commonly,
cell-penetrating peptide (CPP).
Generally, CPPs are deﬁned as short, water-soluble and
partly hydrophobic, and/or polybasic peptides (at most 30–
35 amino acids residues) with a net positive charge at
p h y s i o l o g i c a lp H[ 1]. The main feature of CPPs is that they
are able to penetrate the cell membrane at low micromolar
concentrations in vivo and in vitro without using any
chiral receptors and without causing signiﬁcant membrane
damage. Furthermore, and even more importantly, these
peptides are capable of internalizing electrostatically or
covalently bound biologically active cargoes such as drugs
with high eﬃciency and low toxicity [1, 2].
This new class of peptides was introduced in the late
1980s by the discovery of the human immunodeﬁciency
virus type 1 (HIV-1) encoded TAT peptide [3, 4]a n d
the amphiphilic Drosophila Antennapedia homeodomain-
derived 16 amino acid penetratin peptide (pAntp), which
wasdiscoveredafewyearslater[5–8].Thesetwopeptidesare
the most extensively studied of all CPPs. The mechanism(s)
by which CPPs enter the cells has not been completely
understood.
There is evidence for both energy-independent processes
and endocytosis in internalization of CPPs. Presently, endo-
cytosis, composed of two steps, endocytotic entry followed
by endosomal escape, is believed to be the most common
uptake mechanism at low CPP concentrations [2, 9].
2. Categories of CPPs
CPPs are categorized into the diﬀerent subgroups based on
their individual properties. One of the classiﬁcations is based2 Journal of Biophysics
Table 1: Some CPPs and their physical properties. aHydrophobicity calculated according to the values from von Heijne scale [10].
Peptide No. of arginines No. of lysines Hydrophobicitya No. of residues Sequence Total charge
R9 [11] 9 — 2.58 9 RRRRRRRRR +9
TAT(48–60) [4] 6 2 2.37 13 GRKKRRQRRRPPQ +8
Penetratin [7] 3 4 1.52 16 RQIKIWFQNRRMKWKK +7
Pen-Arg [12] 7 — 1.49 16 RQIRIWFQNRRMRWRR +7
pVEC [13] 4 2 1.10 18 LLIILRRRIRKQAHAHSK +8
M918 [14] 7 — 0.93 22 MVTVLFRRLRIRRACGPPRVRV +7
TP10 [15] — 4 0.53 21 AGYLLGKINLKALAALAKKIL +4
on the origin of the peptide. It includes protein-derived
peptides such as TAT and penetratin, which are also called
protein transductiondomains (PTDs).The secondsubgroup
is the chimeric peptides which may contain two or more
motifs fromother peptides, forinstance, transportan derived
from mastoparan and galanin and its shorter analogue TP10.
Synthetic peptides are another group in this category such as
the polyarginine family [2, 16].
CPPs can also be divided into three other classes based
upon diﬀerent peptide sequences and binding properties
to the lipids. These classes include primary amphipathic,
secondary amphipathic and nonamphipathic CPPs [17].
Primary amphipathic CPPs (paCPPs), such as transportan
[18]o rT P 1 0[ 15] contain typically more than 20 amino
acids. They have sequentially hydrophobic and hydrophilic
residues along their primary structure [17]. In addition
to endocytosis, the proposed mechanism for this group
of CPPs is direct membrane transduction. Model studies
have suggested that the direct transduction occurs via pore
formation, carpet-like perturbations, or inverted micelles
formed in the bilayer membrane. These mechanisms are
described in [19]. Some primary amphiphatic CPPs such
as TP10 are toxic to cells even at low concentrations. In
addition, amphiphatic CPPs interact with both natural and
anionic lipid membranes [17].
Secondary amphipathic CPPs (saCPPs), such as pen-
etratin [7], pVEC [13], and M918 [14]o f t e nc o n t a i na
smaller number of amino acids compared with primary
amphiphatic CPPs. Their amphiphatic property is revealed
whentheyformanalpha-helixorabetasheetstructureupon
interaction with a phospholipid membrane. They typically
bind to model membranes with a certain fraction of anionic
lipids [17].
The third class, that is, the nonamphipathic peptides
(naCPPs) are rather short with a high content of cationic
amino acids (arginine) such as R9 [11] and TAT(48–60)
[3, 4]. They bind to the lipid membrane with a high amount
of anionic lipids. Membrane leakage is not observed at low
micromolar concentrations.
naCPPs and saCPPs are both less toxic than paCPPs, and
higher concentrations or application of a transmembrane
potential seems to be required to make the membrane
unstable, both in the cell and in membrane model systems.
It has been shown that acylation of these cationic peptides to
make them more hydrophobic is a way to induce membrane
leakage by this class of CPPs [20].
Table 1 shows examples of CPPs that have been studied
and mentioned in this paper together with some of their
physical properties.
3.Methods toStudyCPP Uptake and
theMechanism(s)of Uptake
Despite many studies made on CPPs, the mechanism(s)
by which CPPs enter the cells has not been completely
resolved. Diﬀerent biological and biophysical methods have
been utilized to study the cellular uptake mechanism(s) and
to follow CPPs and their conjugates inside the cells. There is
no speciﬁc method which could give a complete answer for
all questions. Therefore, a combination of diﬀerent methods,
model systems and techniques are required.
3.1. Biological Methods Using Cell Cultures
3.1.1. Methods to Study Quantitative CPP and/or Cargo
Uptake. The most common method to evaluate CPP uptake
is by coupling a peptide to a ﬂuorophore and measuring
the ﬂuorescence of treated cells. It is a convenient method
and has been used to study both localization and amount of
uptake of CPPs. Drawbacks to this method are that uptake
does not always correlate with bioavailability, and care must
therefore be taken when interpreting results of these kinds
of studies. Furthermore, cationic CPPs are known to bind to
the outside of the cell membrane and can thereby give false
positive results, as ﬂuorescence analysis cannot discriminate
between internalized or surface bound CPPs. Protocols to
reduce signals from surface bound CPPs include treating
cells with trypsin to remove surface bound CPPs [21]a n d
ﬂuorescence quenching of surface bound ﬂuorophores.
Fluorescence-assisted cell sorting (FACS) is a frequently
used method to quantitatively measure uptake of labeled
CPPs. A cell sorter apparatus sorts cells based upon the
intensity of ﬂuorescence and measures the amount of cells
that have taken up the CPPs. However, FACS analysis cannot
discriminate between surface bound and translocated ﬂuo-
rescence, so the above-mentioned protocols must be used.
In live cells, by confocal microscopy imaging, one is able
to monitor intracellular localization of CPPs or associated
cargo molecules taken up by the cells. Using this method,
it is possible to discriminate between extracellular and
internalized peptides inside, for example, endosomes or theJournal of Biophysics 3
nucleus.Limitationsassociatedwithconfocalmicroscopyare
associated with statistical problems (due to small number of
cells monitored), cost, and expertise needed to perform the
experiments.
Functional assays can be performed to observe biological
responses as well as evaluating their mechanism of uptake.
One such method is the Cre-recombinase assay. It makes
use of Cre-mediated recombination of the loxP-STOP-loxP
EGFP-reporter gene giving rise to expression of EGFP. The
recombination can only take place upon exogenous Cre-
protein delivery to the nucleus [22]. The splice switching
assay is another useful functional assay developed by Kole
and coworkers [23, 24]. In this method, the cell lines are
stably transfected with a plasmid carrying a luciferase gene
and having an aberrant splice site. If a complementary ON
could block this splice site, correct splicing of the luciferase
gene towards the functional luciferase can be achieved.
Luciferase activity measurements indicate the successful
delivery of ON reaching the target. Internalization of the ON
is achieved by using diﬀerent CPPs.
3.1.2. Methods to Study Molecular Mechanism of Uptake.
There are also several other experimental methods to
qualitatively investigate the cellular uptake mechanism. By
inhibiting one or more pathways, it is in principle possible to
ﬁnd the mechanism(s) responsible for the uptake. One com-
monwaytoassessinvolvement ofendocytosis is treatmentof
cells with peptide at 4◦C which inhibits all energy-dependent
pathways [25].
Speciﬁc endocytosis inhibitors are frequently used to
determine the mechanism of uptake of CPPs. Using such
inhibitors, it was shown that uptake of TAT(48–60) was
inhibitedbycytochalasinD,aninhibitorofmacropinocytosis
[26]. These results were corroborated by another study,
where uptake of TAT fusion protein was inhibited by
amiloride,anotherinhibitorofmacropinocytosis[22].There
are problems with using inhibitors to determine mechanism
of uptake as the inhibitor might not be fully speciﬁc [27].
Also, shutting down one uptake route might induce uptake
through another mechanism that is normally inactive.
For investigation of uptake mechanisms, colocalization
withendocytosismarkershasalsobeenstudied.Thismethod
can also be used to determine the intracellular fate of CPPs.
For example, lysotracker red, a substance that emits light in
acidicconditions,canbeusedtodetermineifCPPscolocalize
with lysosomes [28, 29].
Nowadays, several studies have used the eﬀect of chloro-
quine (CQ) as an inhibitor of endosomal acidiﬁcation and
promoting the eﬃciency of the CPP. In addition, CQ is
also applied to provide evidence for an endocytotic pathway.
The lysosomotropic agent, CQ, is a relatively hydrophobic
weak base with two basic groups. CQ operates by opposing
the pH drop inside the endosome resulting in inhibition of
endosome/lysosome fusion. Therefore, the macromolecule
will be in the endosome for a longer period of time [30, 31].
When the result of a functional assay is aﬀected by CQ, one
may conclude that endocytosis is at least part of the CPP
mechanisms.
Pyrenebutyrate (PB) is an aromatic, hydrophobic, and
negatively charged molecule that interacts electrostatically as
a counterion with positively charged CPPs, particularly with
the guanidinium group on arginine residues. The eﬀect of
PB on cellular uptake, translocation, as well as interaction
of CPPs with model lipid membranes has been studied to
investigate the mechanism of uptake. Upon interaction with
hydrophilic oligoarginine peptides, the hydrophobicity is
increased, and a direct membrane translocation is promoted
according to the current mechanistic model [32–35]. When
PB aﬀects the results of a functional assay, one may conclude
that membrane perturbations are rate limiting for the CPP
activity, either in the endosomal escape process or in the
direct penetration through the plasma membrane.
3.2. Biophysical Methods. Understanding the interactions of
CPPs with model membranes or lipid bilayers contributes
to the understanding of the mechanism(s) of the CPPs
translocation [19]. For this purpose, diﬀerent biophysical
methods and model systems are available. Model mem-
branes, particularly large unilamellar phospholipid vesicles
(LUVs) are the most commonly used in the lipid-peptide
interaction studies. Experimental conditions such as peptide
concentration, membrane lipid composition, and charge of
the lipids are important factors in biophysical studies of the
uptake mechanism.
The biophysical LUV leakage studies are indicators of the
degree of perturbation to the membrane caused by diﬀerent
CPPs. The results are usually related to the direct penetration
or endosomal escape of CPPs.
Sometechniquessuchascirculardichroism,ﬂuorescence
and nuclear magnetic resonance are common biophysical
spectroscopiesthatgivemorespeciﬁcinformationaboutsec-
ondary structure, membrane interaction, and 3D-structure
respectively. Molecular modeling is another method used for
simulating the interaction of the CPP with the membrane.
4.Uptake Mechanisms
Despite some common properties of CPPs, especially their
cationic nature, it is believed that the translocation mech-
anism is not the same for diﬀerent families of CPPs. Also,
most CPPs utilize two or more pathways depending on the
experimental conditions. Here, we have brieﬂy reviewed the
two major cellular uptake mechanisms, nonendocytotic or
energy-independentpathwaysandtheendocytoticpathways.
4.1. Direct Penetration. Direct penetration via energy-
independent pathways may include diﬀerent mechanisms
that have been described as inverted micelle formation [8],
pore formation [36], the carpet-like model [37] and the
membrane thinning model [38]. The ﬁrst step in all these
mechanisms constitutes interaction of the positively charged
CPP with negatively charged components of membrane
such as heparan sulfate (HS) as well as the phospholipid
bilayer. They involve stable or transient destabilization of
the membrane associated with folding of the peptide on the
lipid membrane [12, 22, 39]. The subsequent mechanism of4 Journal of Biophysics
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Figure 1: Scheme for diﬀerent suggested uptake pathways for CPPs.
internalization depends highly on the peptide concentration,
peptide sequence, and lipid composition in each model
membrane study.
Generally, direct penetration is most probable at high
CPP concentrations and for primary amphiphatic CPPs such
as transportan analogues and MPG [40–42].
The “inverted micelle” is one model suggested already
at an early stage for the direct penetration of penetratin
[43]. In addition to the interaction between the positively
charged CPP and negatively charged components of the lipid
membrane, interaction between hydrophobic residues such
as tryptophan and the hydrophobic part of the membrane is
also shown to be involved in this mechanism. Therefore, this
mechanism is not probable for the highly cationic CPPs such
as TAT(48–60).
Pore formation includes descriptions by the barrel stave
modelandthetoroidalmodel[36].Inthebarrelstavemodel,
h e l i c a lC P P sf o r mab a r r e lb yw h i c hh y d r o p h o b i cr e s i d u e s
are close to the lipid chains, and hydrophilic residues form
the central pore. In the toroidal model, lipids bend in a
way that the CPP is always close to the headgroup, and
both CPP and lipids form a pore. In both mechanisms,
pores appear when the concentration of the peptide is more
than a certain concentration threshold, which is diﬀerent for
diﬀerent peptides.
In the carpet-like model [37] and membrane thinning
model [38], interactions between negatively charged phos-
pholipidandcationicCPPsresultinacarpetingandthinning
of the membrane, respectively. Subsequent translocation of
the CPP is achieved when CPP concentration is above a
threshold concentration.
4.2. Endocytosis. Endocytosis consists of several pathways
including phagocytosis for uptake of large particles and
pinocytosis for solute uptake. Pinocytosis is categorized
as macropinocytosis, endocytosis dependent on the coat
proteins clathrin or caveolin, or endocytosis independent of
clathrin and/or caveolin (Figure 1)[ 44, 45].
Macropinocytosis is associated with the inward folding
of the outer surface of the plasma membrane, which
results in the formation of vesicles called macropinosomes.Journal of Biophysics 5
Resulting macropinosomes are surrounded by membrane
similar to the cell membrane. Dynamin protein is required
for membrane invagination.
In receptor-mediated endocytosis, clathrin or caveolin
pits are involved in the mechanism of uptake. Both clathrin
andcaveolinproteinscovertheintracellularpartofthemem-
brane. They are required for invagination of the membrane
and help to form the vesicles after binding the extracellular
molecule to the membrane receptor. Clathrin-coated vesicles
are about a few hundred nanometers in diameter, while
caveolin-coated are about 50–80nm in diameter [44, 45].
Earlier studies had suggested that direct penetration was
the uptake mechanism for most CPPs. This conclusion was
based on the observation that peptides enter the cell even at
4◦C,therefore,byanenergy-independentroute.Laterstudies
showed that experimental artifacts were responsible for this
conclusion. Using methanol or formaldehyde to ﬁx the
investigated cells for confocal microscopy may result in some
experimental artifacts [21, 46]. Nowadays by using trypsin
to remove outside associated peptides and live cell confocal
microscopy, one generally avoids this problem [21]. For
most CPPs, it is now generally concluded that endocytosis
is involved in the translocation mechanism. However it is
mostlikelythatdiﬀerentmechanismsoperateunderdiﬀerent
conditions for all CPPs.
5.FactorsAffectingtheMechanismof
Cellular Uptake
In the study of the uptake mechanisms, both physicochem-
ical properties of the CPP and the utilized experimental
conditions are of importance.
Structure activity relationship (S.A.R) studies are able
to recognize the importance of the individual residues in
the CPP sequence. They have shown the importance of
positive charges, especially arginine residues, in the uptake
mechanism as well as hydrophobic alpha helical structures
[11, 47, 48]. It has been shown that most CPPs are rich
in arginine residues and that arginine (and in particular,
its guanidinuim group) is more favorable than lysine for
delivery and CPP activity of the peptides [12, 41, 49, 50].
However, this is not the case considering the high eﬀect
of TP10 and some other CPPs lacking arginine in their
sequences. The CPP conformation and the length of the
CPP sequence are other factors aﬀecting the mechanism
of uptake. This is shown by the diﬀerence between pVEC
and scrambled pVEC in the uptake eﬃciency. The latter
has no uptake, whereas the former eﬃciently translocates
into various cell lines [48, 51]. Thermodynamic binding
studies have shown that primary and secondary amphiphatic
CPPs can directly penetrate through the cell membrane at
low micromolar concentrations. However, non-amphiphatic
CPPs mainly use endocytosis at low concentrations [17].
CPP conformations including induced alpha helices and
beta sheets are also important in explaining the membrane
perturbation and subsequent translocation by CPPs.
Contradictory results are often reported which may
arise from experimental conditions that diﬀer in important
respects. The ﬁrst important factor is the CPP concentration,
which aﬀects the mechanism of CPP entry. Direct pene-
tration is more probable for primary hydrophobic CPPs
at high concentrations, whereas endocytosis is the main
uptake mechanism at low concentrations. The concentration
threshold for direct penetration varies between diﬀerent
CPPs, diﬀerent cell lines, and the presence of and type of
cargo.
It should be emphasized that the presence of the cargo
may alter the CPP uptake pathway. Type of the cargo as well
as the size and binding methodology have been shown to
inﬂuencetheCPPtranslocationmechanism.TATattachedto
a large cargo is mostly entrapped in the endosomal vesicles;
however, it redistributes throughout the cell cytosol when
attached to a small cargo [52]. Furthermore, labeling a
peptide with diﬀerent ﬂuorophores may also inﬂuence the
uptake mechanism, intracellular distribution, and cytotoxi-
city of the peptide [53, 54]. Other experimental factors of
importance for the uptake mechanisms are, for example, cell
type, temperature, and incubation time.
6.Uptake Mechanism(s) for SelectedCPPs
The CPPs described in Table 1 were divided into three
diﬀerent subgroups based on hydrophobicity, namely,
hydrophilic or arginine-rich CPPs (R9 and TAT), intermedi-
ately hydrophobic CPPs (M918, pVEC, Penetratin and Pen-
Arg) and a hydrophobic group, here with only one member
(TP10). These peptides have diﬀerent numbers of arginine
residues, total positive charges, and hydrophobicity. They
could use several diﬀerent pathways for their cellular uptake
and translocation. Generally, two major mechanisms have
been mainly considered: the endosomal pathways composed
of two steps, endocytotic entry followed by endosomal
escape, and direct cell membrane penetration. The exact
molecular pathways underlying their cellular uptake are not
clear .V ariousstudieshaveuseddiﬀerentmethods,inhibitors,
tracer molecules, and model membranes to provide evidence
for the priority of one or more pathways over the others.
We have summarized important mechanistic results
obtained from diﬀerent reports on each investigated CPP.
6.1. Hydrophilic Arginine-Rich CPPs: R9 and TAT(48–60).
TAT(48–60) is derived from the transcription activating
factor of human immunodeﬁciency virus (HIV-1) [4], while
R9 is a synthetic homopolyarginine [11]. TAT(48–60), like
R9, belongs to the hydrophilic group of CPPs but with a
smaller number of arginine residues and more hydrophobic-
ity. Arginine rich CPPs are able to deliver a variety of cargoes
such as peptides, proteins, oligonucleotides, plasmid DNA
and liposomes into mammalian cells in a functionally active
form [55].
In the report by Guterstam et al. [56], direct penetration
is suggested for the hydrophilic, arginine-rich R9, and TAT
in the presence of high PB concentration (50μM). One
reasonis the observed diﬀuse intracellulardistribution of the
peptide as seen by confocal microscopy. However, at lower
concentration of PB, as seen in confocal microscopy, the6 Journal of Biophysics
translocation of R9-bound ON mainly occurs by arginine-
induced macropinocytosis, since CQ is required to obtain
any splice-switching activity in the functional assay. In the
splice-switching assay, the rate limiting step is endosomal
escape which is promoted by hydrophobic counteranion PB.
PB also increased to a small but signiﬁcant extent the calcein
leakage from POPC LUVs which indicates the probable
contribution of pore formation or membrane perturbation
for R9 translocation [56]. In several other studies, punctate
cytoplasmic localization of labeled TAT and R9 observed
by live cell imaging shows the participation of endocytosis
in the uptake mechanism [21, 22, 57]. In contrast, another
studyhasshownthepresenceofanenergy-andtemperature-
independent pathway for some arginine-rich CPPs [12].
Similar observations are made in the presence of cargo.
Recentstudieshaveshownthatdiﬀerent types of endocytotic
pathways are involved in the uptake mechanism of arginine
rich CPPs alone and when conjugated with the cargo
molecules [22, 26, 55, 57–61]. The nature of the cell lines
and the presence and type of the cargo may aﬀect the speciﬁc
mechanism employed by the CPP.
Guterstam and coauthors describe that TAT-ON delivery
is not as eﬃcient as with R9 in the splice-switching assay.
For TAT-ON, ON translocation through the endosome is
probably a rate-limiting step in this assay. Similar to R9, the
presence of PB has only little eﬀect on calcein release from
charged and uncharged LUVs [56].
Another important factor is the participation of heparan
sulfateproteoglycansintheinteractionbetweenargininerich
CPPs and the cell membrane leading to cellular internaliza-
tion [62–64].
6.2. Intermediately Hydrophobic CPPs; M918, Penetratin
and pVEC. They all belong to secondary amphiphatic
or intermediately hydrophobic CPPs (Table 1). pVEC is
derived from the murine vascular endothelial-cadherin (VE-
cadherin) protein. It has been shown that pVEC is able
to translocate into diﬀerent cell lines [13]. S.A.R studies
have shown the eﬀect of arginine and more importantly N-
terminal hydrophobic residues in the translocation ability
of pVEC both with and without the cargo [48]. Treatment
o ft h ec e l l sw i t hd i ﬀerent endocytosis inhibitors eﬃciently
suppresses the cellular uptake of pVEC. This eﬀect is more
pronounced for wortmannin indicating the presence of
the clathrin dependent endocytotic pathway [48]. However
uptake at low temperatures conﬁrms the presence of non-
endocytotic pathways in the pVEC uptake mechanism. The
conjugate of pVEC with avidin translocates through the
membrane by using clathrin dependent endocytosis, but the
presence of another mechanism is also most likely under
diﬀerent conditions [57]. Guterstam et al. [56] describe the
eﬀect of PB on both biophysical and biological endpoints for
pVEC. The ﬂuorescent dye calcein leaked out signiﬁcantly
more from membrane vesicles (LUVs) in the presence than
in the absence of PB, but the biological endpoints were not
aﬀected by PB. Therefore the rate limiting step for pVEC is
probably related to the endocytotic entry rather than to the
endocytotic escape.
M918 is a novel CPP with 22 residues, seven of them
positively charged. It is more hydrophilic than TP10 but
more hydrophobic than penetratin (Table 1). M918 is able to
deliver various cargo molecules into diﬀerent cell lines. The
presence of endocytosis inhibitors and lowering of temper-
ature impaired the cellular internalization, conﬁrming the
presence of endocytotic pathways (especially macropinocy-
tosis) in the uptake mechanism. However unlike for arginine
rich CPPs, glycoaminoglycans on the cell membrane are not
involved in cellular uptake mechanism. The same uptake
mechanisms were observed in the absence or presence
of cargo molecules. The splice correction assay conﬁrms
translocation and bioavailability of the cargo attached to the
peptide [14].
Penetratin,thefragmentofAntennapediahomeodomain
with 16 residues is one of the most extensively used and
studied CPPs [7]. It may be classiﬁed as an intermediately
hydrophobic CPP [56]. However, in certain studies pene-
tratin with seven positively charged residues has been classi-
ﬁed as an arginine rich CPP. Therefore they share a common
mechanism of cell entry with these CPPs. The majority of
reports on the penetratin cellular uptake mechanism suggest
that endocytosis is the major mechanism of uptake, both in
the absence or presence of the cargo molecules. On the other
hand, like arginine rich CPPs, diﬀerent types of endocytotic
pathways for penetratin and its cargo conjugates have been
reported [22,26,55,57–61].Membraneperturbationstudies
using calcein leakage experiments revealed that penetratin
also shares some properties with intermediately hydrophobic
CPPs. Like pVEC and M918, penetratin caused calcein to
leak out more quantitatively from membrane vesicles in the
presence of PB, but PB had no eﬀect in the splice correcting
assay [56].
Pen-Arg is a penetratin analogue in which the lysines
are exchanged to arginines. The cellular uptake of Pen-Arg
and the splice switching activity of cargo conjugated to
Pen-Arg was more eﬃcient than the other intermediately
hydrophobicCPPsinthepresenceofPB.Thisresultindicates
the importance of arginine residues in the interaction with
cell membrane [56].
6.3.HydrophobicCPP:TP10. TP10isatransportananalogue
in which ﬁrst six N-terminal amino acids are removed.
TP10 belongs to the primary hydrophobic CPPs with no
arginine residue, and it shows less toxicity compared to
transportan. Diﬀerent cellular uptake and translocation
mechanisms for TP10 and its cargo conjugates have been
demonstrated. However, the translocation is suggested to
proceed mainly via the endocytotic pathway [65]. Adding
pyrenebutyrate had no eﬀect on uptake eﬃciency and splice-
switching activity of TP10, presumably due to the lack
of arginine residues in its sequence [56]. In that study,
hydrophobic TP10 acted completely in a diﬀerent mode
compared with other studied CPPs. It causes calcein leakage
from membrane vesicles at very low peptide concentrations
[66], and the leakage does not change in the presence of PB
[56].Journal of Biophysics 7
7.NativeCPP-LikePeptides
Besides the native sequences that were originally found to
be CPPs (from the TAT protein [3, 4] or the Antennape-
dia homeodomain [5–8]), there are other native peptide
sequences that have been found to be CPPs. Three examples
will be mentioned here.
The ﬁrst category concerns the dynorphin neuropep-
tide family, where some members like big dynorphin or
dynorphin A have been found to be very eﬃcient CPPs
[67]. They are relatively short, highly basic peptides which
exert a number of important functions in the brain, mostly
mediated by the kappa opioid receptor [68]. However, in
addition the dynorphin neuropeptides are involved in so
called nonopioid functions [69], which seem to depend
on their ability to enter through cell membranes and ﬁnd
molecular interaction partners inside the cell. A speculative
hypothesismakesthistypeofneuropeptidesintotheremains
of an ancient signaling system, before the receptors were
developed,whencell-to-cellsignalingmayhavedependedon
the direct transfer of signaling molecules from one cell to the
next.
A second example is taken from the prion protein,
involved in infectious prion diseases aﬀecting the brain,
like the so-called “mad cow disease”. In diseased tissue, the
protein is transformed from a normal cellular form into a
so-called Scrapie form, which is aggregated and misfolded
[70]. Peptide sequences from mouse or cow including the
signal sequence (about 22 residues, mostly hydrophobic)
followedby6N-terminalresidues(mostlybasic)oftheprion
p r o t e i nh a v eb e e nc h a r a c t e r i z e da sC P P s[ 71]. In addition,
the peptides seem to very speciﬁcally inhibit the formation
of the Scrapie form of the protein inside the infected brain
cells in a cell culture [72].
A third example is the human antibacterial peptide,
LL-37. In addition to its antimicrobial activity which is
associatedtomembranedamage,thepeptidehasbeenshown
to act as a CPP in the eukaryotic host cells [73–75]. The
diﬀerent membrane activities have been explained by the
diﬀerent composition of the prokaryotic and eukaryotic
membranes, with lower overall negative charge associated
with the eukaryotic cell membranes.
8.CPPsandAMPs
AMPs (antimicrobial peptides) involved in host innate
immunity share many structural aspects with CPPs. AMPs
also consist of short sequences of cationic and hydrophobic
peptides [76, 77]. Just like amphiphatic CPPs, upon binding
to the target membrane (bacteria, viruses, fungi, and pro-
tozoa), they form amphiphatic structures. The presence of
cationic residues in AMPs is vital, as it enhances electrostatic
binding to the highly negatively charged membrane of their
target, where the actual antimicrobial activity will begin.
On the other hand, hydrophobic residues drive the entry of
the peptide through the lipid bilayer. In contrast, the cell
membrane of the CPP target is less anionic and has diﬀerent
compositions making it more resistant to AMPs [76].
The mechanism of action is not completely resolved for
AMPs. Like CPPs, AMPs may use more than one mechanism
ofactiondependingonthenatureoftheAMPandthetarget.
Mechanisms include transient or static pore formation and
detergent-like solubilization. Diﬀerent models have been
proposed for describing these mechanisms: barrel-stave,
toroid-pore, and the carpet-like models [76]. Recent work
has shown the importance of the thermodynamics of the
insertion of the peptide into the membrane in determination
of the mechanism of action [78] .T h e s em o d e l sc a na l s o
explain the transient membrane perturbation and subse-
quent cellular uptake for certain CPPs, especially primary
amphiphatic CPPs such as transportan analogues [40–42].
There is a generally accepted view that association of
the peptide to the membrane is the ﬁrst step leading to
destabilizing the membrane for both groups of peptides
[12, 76]. The consequent cell entry highly depends on factors
such as peptide and target properties. For certain CPPs
which do not have high aﬃnity for binding to or the ability
to perturb the cell membrane, cellular uptake occurs via
endocytosis as an alternative. In this case, the presence of
proteogycans is necessary to promote the uptake [79]. The
endocytotic pathway is not the entry route for AMPs as their
bacterial targets lack factors necessary for the endocytotic
pathway [76, 80]. As a result of these diﬀerences, AMPs have
the ability to kill pathogenic agents, but most of them do not
signiﬁcantly harm the host cells. However, some AMPs are
also toxic to the host cells [81]. In sharp contrast, CPPs are
considered to internalize into the host cell and translocate
diﬀerent cargo molecules without causing any signiﬁcant
damage.
As a conclusion, these two groups of peptides are very
similar from the molecular point of view, although they
target diﬀerent kinds of cell membranes. The observation
that some CPPs such as TP10 and pVEC are also able to
enter bacteria and act as antimicrobial peptides has made
this group even more interesting [82]. On the other hand,
some nonlytic AMPs have the ability to translocate across
biologicalmembraneofhostcellsinanondisruptivewayand
even translocate cargo molecules into the cells [83]. Because
of such similarities, some authors have put forward the idea
that AMPs and CPPs could be classiﬁed as one group called
membrane active peptides.
9. Conclusion
This paper concerns various aspects of CPPs, including their
physicochemical properties, and mechanism(s) of cellular
uptake and membrane translocation.
The CPPs represent a potentially valuable tool for the
cellular delivery of important cargo molecules, considering
their low toxicity and independence of membrane receptors
and cell types. Since the discovery of the two well-known
CPPs, the TAT and penetratin peptides, the number of
known CPPs has considerably increased and their properties
have been elucidated. Numerous preclinical applications for
the treatment of certain diseases have been found due to the
drug-delivery capabilities of the CPPs.8 Journal of Biophysics
Despite the similarities among CPPs, the mechanism(s)
of their action may vary considerably. Contradictory obser-
vations indicate the presence of diﬀerent factors which aﬀect
the cellular uptake and translocation mechanism(s). So far,
most reports have pointed out endocytosis as the major
cellular uptake pathway for most CPPs. However, there are
still remaining important questions such as, what are the
exact uptake mechanisms, how do diﬀerent cargo molecules
inﬂuence the cellular uptake of CPPs, and what are the
additional aspects aﬀecting the bioavailability of the CPPs?
The answers to these questions may be found by systematic
comparisons between uptake mechanisms of diﬀerent CPPs
both in the absence and presence of a variety of cargo
molecules.
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